ATRA
Atara Biotherapeutics Inc
9.20$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,401.6% | -1,185.5% | -108.2% | -37.2% | -9.9% | -74.7% | -28.7% | -41.6% | -283.4% | -357.2% | -595.5% | -529.8% | -353.5% | |
| 56.5% | 28.3% | 5.1% | 4.6% | 3.1% | 3.4% | 1.8% | 1.3% | 1.0% | 3.1% | 5.6% | -2.4% | 1.6% | |
| 521.2% | 233.5% | 30.7% | 22.1% | 16.0% | 17.8% | 4.3% | 15.9% | 35.5% | 95.1% | 145.2% | 62.5% | 62.7% | |
| 92.2% | -171.1% | -42.9% | -11.8% | 16.3% | -68.4% | -83.7% | -72.7% | -228.1% | -123.8% | -146.1% | 111.4% | -159.9% | |
| 13.1% | 1.0% | 0.5% | 0.1% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 3,295.0% | 233.9% | 53.8% | 25.1% | -41.5% | 10.3% | 17.5% | -28.8% | -70.1% | 529.2% | – | -1,051.7% | – | |
| – | 2.2% | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -0.5% | -0.7% | -0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -9.7% | 35.6% | 88.2% | -1.1% | 89.1% | -1.0% | -0.3% | 87.1% | 30.3% | -0.2% | 571.9% | 765.9% | 142.4% | |
| 883.7% | -916.0% | 33.8% | -13.2% | 37.7% | -65.4% | -11.4% | 16.6% | -323.2% | 171.8% | -23.6% | -815.7% | -220.9% | |
| -2,414.7% | -1,186.5% | -108.7% | -37.3% | -9.9% | -75.0% | -28.7% | -41.6% | -283.4% | -357.2% | -595.5% | -529.8% | -353.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.